An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and sellers on messaging platforms, based on recent findings.
Experimental Drug Gaining Traction Online
Retatrutide, which is still in research studies, is being promoted by online personalities for its supposed fat-burning effects. Viewers are encouraged to message these profiles directly for source information, while also obtaining promotional offers.
Active Trade on Social Networks
Additionally, a flourishing trade exists on messaging services, where groups with thousands of members share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors promote the drug there before redirecting buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Professionals Voice Concerns
Nevertheless, doctors and chemists have cautions that the sale of what remains an unapproved drug in the UK is a cause for concern and could lead to users injecting substances of unknown origin.
Some professionals said the popularity for retatrutide could be linked to the increasing cost of approved weight loss products such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.
Some content creators try to sidestep the rules by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still violate medicines, advertising, and consumer regulations, risking penalties, legal action or imprisonment.
Platform Response and Material Removal
Based on TikTok, the service has taken down problematic content and banned related keywords and query recommendations. The company stated it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also found communities with up to 9,000 participants marketing retatrutide using the platform's built-in discovery tool, which operates like a public directory. Typing “retatrutide” instantly brings up groups with thousands of members, filled with images of weight loss, glowing reviews and step-by-step instructions for preparing or injecting at residence.
Within minutes of entering one group, a vendor shared WhatsApp details, where most purchases occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed testing documentation. Not one inquired about body mass, health issues or previous experience.
Product Details and Pricing
Within these groups, posts show black plastic parcels with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens usually sold at £160 for 20mg. When asked how much time a injector should be used, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Service Oversight and Security Measures
A spokesperson for Telegram stated it actively monitored harmful content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are injecting substances they cannot confirm. Although the science behind this drug is valid, these digital products may not include what they claim,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit injections are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.
Her team has previously encountered patients injured by self-injection from unconfirmed sources. “We understand the disappointment, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational substance not yet authorized … may expose patients to possibly significant medical dangers”.
